Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ometric was a specialized technology company that developed real-time, in-line chemical monitoring solutions primarily for the pharmaceutical, chemical, and food industries. The company's core innovation, Multivariate Optical Computing (MOC), utilized proprietary optical filters to perform complex chemical analysis instantly without the need for traditional spectrometers or extensive sample preparation. This technology allowed pharmaceutical manufacturers to monitor critical processes such as blending, drying, and granulation in real-time, significantly improving quality control and manufacturing efficiency. Ometric was acquired by Halliburton in 2011 to adapt its advanced sensing capabilities for the oil and gas sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ometric.